- Home
- GSHD vs CLDX Comparison
GSHD vs CLDX Comparison
Compare GSHD & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GSHD | CLDX |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | GSHD | CLDX |
|---|---|---|
| Price | $72.44 | $40.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $72.50 | $46.60 |
| AVG Volume (30 Days) | 503.7K | ★ 933.3K |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.04 | N/A |
| Revenue | ★ $365,304,000.00 | $12,743,000.00 |
| Revenue This Year | $16.40 | $111.39 |
| Revenue Next Year | $18.53 | $235.85 |
| P/E Ratio | $67.98 | ★ N/A |
| Revenue Growth | 16.15 | ★ 87.78 |
| 52 Week Low | $33.68 | $21.34 |
| 52 Week High | $89.24 | $45.14 |
Technical Indicators
Market Signals| Indicator | GSHD | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 67.18 | 54.46 |
| Support Level | $69.74 | $28.51 |
| Resistance Level | $77.89 | $45.14 |
| Average True Range (ATR) | 3.09 | 1.75 |
| MACD | -0.08 | -0.30 |
| Stochastic Oscillator | 93.09 | 42.37 |
Price Performance
Historical ComparisonAbout GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions. The company is has a single reportable segment: insurance distribution.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.